Expion Health Announces Qlare™, a Breakthrough Conversational AI Tool Transforming Prescription Cost Decision-Making

North Bethesda, MD, December 4, 2025 — Expion Health announced today the upcoming launch of Qlare™, a major advancement to its ExpionIQ® platform that will reshape how healthcare leaders access and use prescription cost data to make decisions. Qlare will be available in early 2026.

Qlare is the first conversational AI built specifically for prescription cost analysis, introducing a faster, more intuitive way for users to access insights from ExpionIQ. While clients can continue using the robust dashboards and visual analytics they rely on, Qlare enhances the experience by allowing decision-makers to simply ask questions and receive clear, data-informed answers within seconds. Powered by large language models and Expion's proprietary rebate and pharmacy datasets, Qlare delivers precise and efficient responses to even complex queries.

"We've brought Qlare to life as a true breakthrough for our clients," said Karin Humphrey, CEO and Chairwoman of the Board at Expion Health. "Pharmacy data has historically been difficult to navigate. Qlare acts like a power user on their behalf — giving decision-makers the ability to simply ask questions and instantly access complex data with clarity and confidence."

The launch of Qlare caps a transformative year for Expion Health. Earlier in 2025, the company undertook a bold strategic realignment, divesting non-pharmacy lines of business to focus exclusively on pharmacy cost management. This expansion has been a key growth driver, helping propel Expion onto the Inc. 5000 list of the fastest-growing private companies in America.

Expion has been on an impressive transformation journey that began with reshaping the company around a bold, technology-first vision and refreshed brand, followed by the elevation of Karin Humphrey to Board Chair. Building on that foundation, Chris Westbrook was promoted to President of Service and Growth, and the company welcomed Jeff Jollon as Chief Financial Officer.

"This year's transformation laid the foundation for what's next," said Chris Westbrook, President of Service and Growth. "With the launch of Qlare, we're challenging the status quo in pharmacy prescription cost management – making it faster and easier to access meaningful insights and empowering clients to make smarter, faster decisions with confidence."

This innovation is consistent with Expion's industry recognition including the CIO100 list and the UiPath AI 10 Award, underscoring its role as a pioneer in applying AI in creative ways across the healthcare space.

About Expion Health

Expion Health is transforming prescription cost management with unbundled, modular solutions. The award-winning ExpionIQ platform leverages advanced AI and analytics to optimize pharmacy and medical rebates, drive specialty drug savings, optimize plan dollars, and enhance underwriting and forecasting to deliver cutting-edge solutions that create new avenues for cost containment. Learn more at www.expionhealth.com.